MedTrace Logo

US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair

NCT04852783 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-03-31

No results posted yet for this study

Summary

The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.

Conditions

  • Aneurysm, Intracranial

Interventions

DEVICE

Contour Neurovascular System

Endovascular embolization of wide-necked, bifurcated saccular intracranial aneurysms.

Sponsors & Collaborators

  • Cerus Endovascular, Inc.

    lead INDUSTRY

Principal Investigators

  • Pascal M Jabbour, MD · Jefferson University Hospitals

  • Demetrius Lopes, MD · Advocate Medical Group - Brain and Spine Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2026-02-20
Completion
2030-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04852783 on ClinicalTrials.gov